Show Stocks and Investing Publications • Tue, October 19, 2021
Brian Skorney Maintained (VRTX) at Buy and Held Target at $240 on, Oct 19th, 2021
-skorney-maintained-vrtx-at-buy-and-held-target-at-240-on-oct-19th-2021.html
Stocks and Investing on Sun, Oct 27th, 2024Brian Skorney of Baird, Maintained "Vertex Pharmaceuticals Incorporated" (VRTX) at Buy and Held Target at $240 on, Oct 19th, 2021.
Brian has made no other calls on VRTX in the last 4 months.
There are 6 other peers that have a rating on VRTX. Out of the 6 peers that are also analyzing VRTX, 2 agree with Brian's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Paul Matteis of "Stifel" Downgraded from Strong Buy to Hold and Decreased Target to $213 on, Thursday, September 9th, 2021
- Danielle Brill of "Raymond James" Initiated at Hold on, Thursday, July 1st, 2021
These are the ratings of the 4 analyists that currently disagree with Brian
- Matthew Harrison of "Morgan Stanley" Downgraded from Hold to Sell and Held Target at $202 on, Tuesday, September 7th, 2021
- Brian Abrahams of "RBC Capital" Maintained at Buy with Increased Target to $248 on, Friday, July 30th, 2021
- Edward Tenthoff of "Piper Sandler" Maintained at Buy with Increased Target to $323 on, Friday, July 30th, 2021
- Geoffrey Porges of "SVB Leerink" Maintained at Sell with Increased Target to $175 on, Friday, July 30th, 2021